Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
:KVUE
KVUE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.67 - $25.17
Previous CloseN/A
Volume2.33M
Average Volume (3M)17.47M
Market Cap
$45.44B
Enterprise Value$54.54B
Total Cash (Recent Filing)$1.07B
Total Debt (Recent Filing)$8.72B
Price to Earnings (P/E)43.2
Beta0.35
Next Earnings
Jul 17, 2025EPS Estimate
0.28Last Dividend Ex-Date
May 14, 2025Dividend Yield3.46%
Share Statistics
EPS (TTM)0.24
Shares Outstanding1,919,909,900
10 Day Avg. Volume13,706,127
30 Day Avg. Volume17,466,536
Financial Highlights & Ratios
PEG Ratio-12.50
Price to Book (P/B)4.84
Price to Sales (P/S)0.00
P/FCF Ratio35.13
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit6.09
Enterprise Value/Ebitda4.11
Forecast
1Y Price Target
$25.18Price Target Upside13.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Kenvue, Inc. News
Bulls Say, Bears Say
Bulls Say
E-commerce GrowthThe portion of Listerine sales online has increased, showing a concerted effort to ramp e-commerce capabilities.
Product InnovationKenvue's innovation engine continues with today's announcement of the globally-recognized Tylenol brand expanding into the supplement market.
Bears Say
Financial ChallengesOperating margin and EPS were trimmed due to the estimated impact of tariffs, indicating potential financial challenges.
Product Liability LawsuitsIt hasn't been smooth sailing for Kenvue since being spun out of JNJ, facing issues like major product liability lawsuits, softening demand, and underinvestment in key brands.
Ownership Overview
1.18% Insiders
35.83% Mutual Funds
13.94% Other Institutional Investors
22.89% Public Companies and Individual Investors
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.67 and its highest was $25.17 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $45.44B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Jul 17, 2025 which is in 42 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on May 08, 2025. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.227 by $0.013.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.816 which represents an annual dividend yield of 3.46%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.28.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,919,909,900 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.24 in its last earnings report, beating expectations of $0.227. Following the earnings report the stock price went up 4.103%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
Kenvue, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.18 (13.37% Upside)
$25.18 (13.37% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 8.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $393.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.78%
12-Months-Change
Fundamentals
Return on Equity
10.22%
Trailing 12-Months
Asset Growth
-3.76%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue, Inc. (KVUE) is a leading global consumer health company that operates across various sectors, including personal health care, skin health, and essential health products. The company is renowned for its portfolio of well-established brands, offering a range of products that cater to health and wellness needs. Kenvue is dedicated to delivering innovative solutions that enhance the quality of life for consumers around the world.
KVUE Company Deck
KVUE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Kenvue, with strong execution of strategic plans and market share gains in certain segments overshadowed by organic sales declines and challenges in the Skin Health and Beauty segment. The impact of tariffs and foreign exchange rates also posed significant challenges.Read More>KVUE Revenue Breakdown
42.23% Self Care
30.33% Essential Health
27.43% Skin Health and Beauty
KVUE Stock 12 Month Forecast
Average Price Target
$25.18
▲(13.37%Upside)